vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and MetLife (MET). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $600.0M, roughly 1.8× MetLife). MetLife runs the higher net margin — 134.8% vs 12.3%, a 122.6% gap on every dollar of revenue. On growth, MetLife posted the faster year-over-year revenue change (7.9% vs 4.8%). Over the past eight quarters, MetLife's revenue compounded faster (2.0% CAGR vs -1.3%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

ILMN vs MET — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.8× larger
ILMN
$1.1B
$600.0M
MET
Growing faster (revenue YoY)
MET
MET
+3.1% gap
MET
7.9%
4.8%
ILMN
Higher net margin
MET
MET
122.6% more per $
MET
134.8%
12.3%
ILMN
Faster 2-yr revenue CAGR
MET
MET
Annualised
MET
2.0%
-1.3%
ILMN

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
ILMN
ILMN
MET
MET
Revenue
$1.1B
$600.0M
Net Profit
$134.0M
$809.0M
Gross Margin
66.1%
Operating Margin
19.2%
Net Margin
12.3%
134.8%
Revenue YoY
4.8%
7.9%
Net Profit YoY
-36.3%
EPS (diluted)
$0.87
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
MET
MET
Q1 26
$1.1B
Q4 25
$1.2B
$600.0M
Q3 25
$621.0M
Q2 25
$604.0M
Q1 25
$611.0M
Q4 24
$1.1B
$556.0M
Q3 24
$1.1B
$554.0M
Q2 24
$1.1B
$558.0M
Net Profit
ILMN
ILMN
MET
MET
Q1 26
$134.0M
Q4 25
$334.0M
$809.0M
Q3 25
$896.0M
Q2 25
$729.0M
Q1 25
$945.0M
Q4 24
$186.0M
$1.3B
Q3 24
$705.0M
$1.3B
Q2 24
$-2.0B
$946.0M
Gross Margin
ILMN
ILMN
MET
MET
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
ILMN
ILMN
MET
MET
Q1 26
19.2%
Q4 25
17.4%
Q3 25
Q2 25
Q1 25
Q4 24
15.8%
Q3 24
68.6%
Q2 24
-147.2%
Net Margin
ILMN
ILMN
MET
MET
Q1 26
12.3%
Q4 25
28.8%
134.8%
Q3 25
144.3%
Q2 25
120.7%
Q1 25
154.7%
Q4 24
16.8%
228.6%
Q3 24
65.3%
242.2%
Q2 24
-178.8%
169.5%
EPS (diluted)
ILMN
ILMN
MET
MET
Q1 26
$0.87
Q4 25
$2.16
$1.18
Q3 25
$1.22
Q2 25
$1.03
Q1 25
$1.28
Q4 24
$1.16
$1.75
Q3 24
$4.42
$1.81
Q2 24
$-12.48
$1.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
MET
MET
Cash + ST InvestmentsLiquidity on hand
$1.2B
$25.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$28.4B
Total Assets
$6.6B
$745.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
MET
MET
Q1 26
$1.2B
Q4 25
$1.6B
$25.6B
Q3 25
$26.2B
Q2 25
$27.5B
Q1 25
$26.9B
Q4 24
$93.0M
$25.2B
Q3 24
$70.0M
$26.4B
Q2 24
$74.0M
$24.6B
Stockholders' Equity
ILMN
ILMN
MET
MET
Q1 26
$2.7B
Q4 25
$2.7B
$28.4B
Q3 25
$28.9B
Q2 25
$27.7B
Q1 25
$27.5B
Q4 24
$2.4B
$27.4B
Q3 24
$2.1B
$30.9B
Q2 24
$1.4B
$27.3B
Total Assets
ILMN
ILMN
MET
MET
Q1 26
$6.6B
Q4 25
$6.6B
$745.2B
Q3 25
$719.7B
Q2 25
$702.5B
Q1 25
$688.3B
Q4 24
$6.3B
$677.5B
Q3 24
$6.0B
$705.0B
Q2 24
$6.1B
$675.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
MET
MET
Operating Cash FlowLast quarter
$289.0M
$7.1B
Free Cash FlowOCF − Capex
$251.0M
FCF MarginFCF / Revenue
23.0%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.16×
8.75×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
MET
MET
Q1 26
$289.0M
Q4 25
$321.0M
$7.1B
Q3 25
$3.6B
Q2 25
$2.2B
Q1 25
$4.3B
Q4 24
$364.0M
$4.6B
Q3 24
$316.0M
$4.2B
Q2 24
$80.0M
$3.5B
Free Cash Flow
ILMN
ILMN
MET
MET
Q1 26
$251.0M
Q4 25
$267.0M
Q3 25
Q2 25
Q1 25
Q4 24
$335.0M
Q3 24
$284.0M
Q2 24
$49.0M
FCF Margin
ILMN
ILMN
MET
MET
Q1 26
23.0%
Q4 25
23.0%
Q3 25
Q2 25
Q1 25
Q4 24
30.3%
Q3 24
26.3%
Q2 24
4.4%
Capex Intensity
ILMN
ILMN
MET
MET
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.6%
Q3 24
3.0%
Q2 24
2.8%
Cash Conversion
ILMN
ILMN
MET
MET
Q1 26
2.16×
Q4 25
0.96×
8.75×
Q3 25
3.98×
Q2 25
3.00×
Q1 25
4.51×
Q4 24
1.96×
3.63×
Q3 24
0.45×
3.11×
Q2 24
3.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

MET
MET

Other$165.0M28%
Prepaidlegalplansandadministrativeonlycontracts$158.0M26%
Vision Fee For Service Arrangements$140.0M23%
Administrative Service$76.0M13%
Distribution Service$36.0M6%
Feebasedinvestmentmanagementservices$25.0M4%

Related Comparisons